Women Have Worse Outcomes During 36 Months After ACS

Share this content:
Women Have Worse Outcomes During 36 Months After ACS
Women Have Worse Outcomes During 36 Months After ACS

FRIDAY, Nov. 4, 2016 (HealthDay News) -- In a study published in the Nov. 1 issue of The American Journal of Cardiology, among patients with acute coronary syndrome (ACS), women were found to have a higher mortality rate than men during 36 months of follow-up.

Przemyslaw Trzeciak, M.D., Ph.D., from the Medical University of Silesia in Katowice, Poland, and colleagues analyzed 932 patients aged <40 years with ACS from the Silesia region in Poland. Participants were followed for a composite end point of death, ACS recurrence, a need for percutaneous coronary intervention, and coronary artery bypass graft surgery within 12 and 36 months after ACS.

The researchers found that within 12 months after ACS there was no significant difference in mortality (4.8 versus 3.1 percent; P = 0.29) or the composite end point (21.6 versus 16.0 percent; P = 0.14). Within the 36-month follow-up period, women had a higher incidence of the composite end point than men (28.4 versus 20.1 percent; P = 0.04), and there was a trend toward higher mortality (9.2 versus 5.0 percent; P = 0.055). In multivariate analysis, female gender was an independent risk factor for death (hazard ratio, 2.76).

"Women had a higher incidence of the composite end point and showed a tendency toward a higher mortality than the men within the 36-month follow-up period," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »